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Transcriptional activation of 
follistatin by Nrf2 protects 
pulmonary epithelial cells against 
silica nanoparticle-induced 
oxidative stress
Chen Lin1,*, Xinyuan Zhao1,*, Desen Sun1,3, Lingda Zhang1, Wenpan Fang1, Tingjia Zhu1, 
Qiang Wang1, Botao Liu4, Saisai Wei3, Guangdi Chen1,3, Zhengping Xu1,2,3 & Xiangwei Gao1,3
Silica nanoparticles (SiO2 NPs) cause oxidative stress in respiratory system. Meanwhile, human cells 
launch adaptive responses to overcome SiO2 NP toxicity. However, besides a few examples, the 
regulation of SiO2 NP-responsive proteins and their functions in SiO2 NP response remain largely 
unknown. In this study, we demonstrated that SiO2 NP induced the expression of follistatin (FST), a 
stress responsive gene, in mouse lung tissue as well as in human lung epithelial cells (A549). The levels 
of Ac-H3(K9/18) and H3K4me2, two active gene markers, at FST promoter region were significantly 
increased during SiO2 NP treatment. The induction of FST transcription was mediated by the nuclear 
factor erythroid 2-related factor 2 (Nrf2), as evidenced by the decreased FST expression in Nrf2-
deficient cells and the direct binding of Nrf2 to FST promoter region. Down-regulation of FST promoted 
SiO2 NP-induced apoptosis both in cultured cells and in mouse lung tissue. Furthermore, knockdown of 
FST increased while overexpression of FST decreased the expression level of NADPH oxidase 1 (NOX1) 
and NOX5 as well as the production of cellular reactive oxygen species (ROS). Taken together, these 
findings demonstrated a protective role of FST in SiO2 NP-induced oxidative stress and shed light on the 
interaction between SiO2 NPs and biological systems.
Nanoparticles (NPs) are engineered structures with less than 100 nanometers in at least one dimension. These 
materials are increasingly being used for diverse industrial and biomedical applications as well as in consumer 
products1. The wide use of NPs has raised serious concerns about their safety for human health and the environ-
ment. In addition, NPs are different from large particles in physicochemical properties and may potentially result 
in yet unknown toxic effects2,3. Among the engineered nanomaterials, silica nanoparticle (SiO2 NP) is one of the 
most widely applied4. Despite intense investigations, current knowledge of the physiological effects of SiO2 NPs 
on biological barriers and the underlying molecular mechanisms remains fragmented.
The respiratory system is considered to be one of the main routes by which NPs access human body1–3. 
Therefore, the respiratory toxicity of NPs draws great concern. In response to NP exposure, airway epithelial cells 
and macrophages generate reactive oxygen species (ROS) by biologically catalyzed redox reactions. ROS damages 
cellular proteins, lipids, and DNA1,5. On the other hand, elevated ROS triggers cellular oxidative stress responses 
which are mainly mediated by the activation of nuclear factor erythroid 2-related factor 2 (Nrf2) signaling6. Nrf2 
is a transcription factor which is rapidly degraded under normal condition by ubiquitin-proteasome system. 
During oxidative stress, the protein is stabilized, translocates into the nucleus and thereby induces the expression 
of protective proteins including antioxidant enzymes, detoxification enzymes, and stress-response proteins6,7. 
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These NP-responsive proteins exert antioxidant and cytoprotective effects in lungs. If the protection effect fails, 
escalation of oxidative stress results in mitochondrial perturbation and cell apoptosis1,7,8. However, besides a few 
Nrf2 target genes, the regulation of other SiO2 NP-responsive genes and their functions in SiO2 NP response 
remain largely unknown.
Follistatin (FST) is widely expressed in higher animals and participates in a variety of processes such as cell 
growth, development, differentiation, and secretion9. FST was firstly identified as a secretory protein that binds 
and inactivates transforming growth factor (TGF)-β family members including activin, bone morphogenetic 
proteins (BMPs), and myostatin. The TGF-β -like molecule-neutralizing effect of FST contributes to most of its 
functions10–12. Recent studies showed that FST also plays a protective role under cellular stresses including oxi-
dative stress13–15. For example, activin induces endothelial cell oxidative stress and endothelial cell dysfunction, 
and these effects are mitigated by follistatin15. Follistatin has also been reported to suppress BMP4-induced ROS 
production16. Based on the inhibitory role of FST in cellular ROS production, we proposed that FST participates 
in cellular response to SiO2 NP-induced oxidative stress.
In this study, we evaluated the function of FST in SiO2 NP-induced lung toxicity using both in vitro and 
in vivo models. We found that FST was transcriptionally up-regulated by transcription factor Nrf2 during SiO2 
NP treatment. Our data further demonstrated that FST protected cells against apoptosis through reversing oxida-
tive stress. These data provided evidence to support that FST is an oxidative stress responsive protein contributing 
to lung anti-oxidant response to SiO2 NPs.
Results
Characterization of SiO2 NPs. We first evaluated the size of silica nanoparticles using TEM. Data showed 
that the silica nanoparticles had a spherical shape with the average diameter of 37.3 nm (Fig. 1A). Size measure-
ment by Image J software showed that SiO2 NPs were approximately normally distributed (Fig. 1B). The hydrody-
namic size of silica nanoparticles in culture media RPMI-1640 was 41.36 ± 2.55 nm and the silica nanoparticles 
exhibited good monodispersity. SiO2 NPs are quite stable in RPMI 1640 media since the size did not increase after 
24 h of incubation (41.32 ± 3.19 nm, Table 1). Further, we measured zeta potentials of SiO2 NPs, which provide 
quantitative information on the stability of the particles. Data showed that the absolute value of zeta potentials 
of SiO2 NPs in our study was − 33.28 ± 0.65 and − 35.14 ± 0.71 mV respectively, indicating that the particles are 
more likely to remain dispersed.
SiO2 NP enhances FST expression in mouse lung tissue. FST is up-regulated during glucose depri-
vation and plays a protective role13,14. We hypothesized that FST is also a SiO2 NP-responsive protein. Since lung 
is the major exposure tissue for SiO2 NPs, we detected whether SiO2 NP treatment could induce FST expression 
change in mouse lung tissue. To that end, we intratracheally instilled mice with SiO2 NPs. The mRNA level of 
FST increased (5.7 fold) at 1 day after SiO2 NP instillation and decreased to the basal level 4 days after SiO2 NP 
treatment (Fig. 2A, Fig. S1). Immunoblotting showed that the protein level of FST significantly increased at 1 
Figure 1. Characterization of silica nanoparticles. (A) Transmission electron microscopy image of SiO2 
NPs. (B) Size distribution of SiO2 NPs. Silica nanoparticles exhibited good monodispersity and showed 
approximately normal distribution.
Time 
(hour)
Hydrodynamic 
size (nm)
Zeta potential 
(mV)
Polydispersity 
index
0 41.36 ± 2.55 − 33.28 ± 0.65 0.18 ± 0.02
24 41.32 ± 3.19 − 35.14 ± 0.71 0.19 ± 0.03
Table 1.  Hydrodynamic size, zeta potential, and polydispersity index of SiO2 NPs in RPMI 1640 at 
different time points.
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day after SiO2 NP treatment, while the increase of FST protein at 7 days was not as dramatic as 1 day (Fig. 2B). 
Furthermore, immunohistochemistry staining showed increased expression of FST in SiO2 NP-treated lung tissue 
(Fig. 2C). These data indicated that FST is an early responsive gene to SiO2 NP treatment.
SiO2 NP enhances FST expression in A549 cells. Epithelial cells are the major components of lung 
tissue and essential for lung function. We asked whether the expression of FST in lung epithelial cells increased 
during SiO2 NP treatment. Thus, we treated human epithelial cells A549 with SiO2 NPs and detected FST mRNA 
level. Data showed that SiO2 NP up-regulated FST mRNA level in a dose-dependent manner. 50 μ g/ml of SiO2 
NP treatment induced 8-fold increase of FST mRNA (Fig. 2D). The mRNA level of FST started to increase 1 hour 
after SiO2 NP treatment, while the protein level started to increase at 3 hours of SiO2 NP treatment. The expression 
of FST reached the peak at 24 hours (Fig. 2E,F). These data indicated that SiO2 NP promotes FST expression in 
lung epithelial cells. We also detected the effect of SiO2 NP in normal branchial epithelial cell line BEAS-2B. Data 
showed that SiO2 NP also promoted FST expression in BEAS-2B cells (Fig. S2).
The transcription of FST gene is activated during SiO2 NP treatment. The higher level of FST 
mRNA may result from either transcriptional activation or post-transcriptional regulation14. We first examined 
the stability of FST mRNA. Actinomycin D was used to block de novo RNA synthesis, and then the persistence 
of the existing FST mRNA was measured by quantitative RT-qPCR at 1, 2, 4 and 8 h. Our results revealed that 
the stability of the FST mRNA did not change during SiO2 NP treatment (Fig. 3A). Actually, when de novo RNA 
synthesis was inhibited, FST mRNA level could not increase during SiO2 NP treatment (Fig. S3), suggesting that 
SiO2 NP regulates FST mRNA expression at transcriptional level. Therefore, we detected changes in FST gene 
promoter activity using a luciferase reporter. Data showed that the transcriptional activity of FST promoter region 
was significantly induced under SiO2 NP treatment (Fig. 3B). Since Ac-H3(K9/18) and H3K4me2 are recognized 
as active gene markers17, we further detected the Ac-H3(K9/18) and H3K4me2 levels at FST promoter region 
using chromatin immunoprecipitation. Data showed that SiO2 NP significantly increased both Ac-H3(K9/18) 
Figure 2. SiO2 NP enhances FST expression in mouse lung tissue and in A549 cells. (A–C) Mouse lung was 
instilled with PBS or 100 μ g of SiO2 NPs and harvested at the indicated time. (A) The FST mRNA level in mouse 
lung tissue was measured by real time qPCR and normalized to ACTB mRNA level. (B) The lung tissue protein 
lysates from paired mice were subjected to immunoblotting for FST detection. Two mice were used for each 
group (C: PBS; NP: SiO2 NP). (C) Fixed lung tissues from paired mice were subjected to immunohistochemistry 
with FST antibody. (D) A549 cells were incubated with SiO2 NPs at different concentrations for 12 h. The FST 
mRNA level was measured by real time qPCR. Data are presented as the mean ± SD of three independent 
experiments. *P < 0.05, **P < 0.01. (E,F) A549 cells were incubated with or without 50 μ g/ml of SiO2 NPs and 
harvested at the indicated time. (E) The FST mRNA level was measured by real time qPCR. Data are presented 
as the mean ± SD of three independent experiments. *P < 0.05, **P < 0.01. (F) The FST protein level was 
detected by immunoblotting.
www.nature.com/scientificreports/
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and H3K4me2 levels at FST promoter region (Fig. 3C,D). Ac-H3(K9/18) and H3K4me2 levels at FST promoter 
also increased in SiO2 NP-treated mouse lung tissue (Fig. 3E,F), further supporting that SiO2 NP up-regulates FST 
expression at the transcriptional level.
Nrf2 mediates FST induction during SiO2 NP treatment. The transcriptional factor Nrf2 controls 
stress gene expression during SiO2 NP treatment6,7. To determine the role of endogenous Nrf2 in regulating FST 
Figure 3. The transcription of FST gene is activated during SiO2 NP treatment. (A) A549 cells treated 
with or without SiO2 NPs were incubated with 5 μ g/ml of actinomycin D for 1, 2, 4 and 8 h. FST mRNA level 
was measured and normalized to ACTB mRNA level. (B) A549 cells transfected with FST promoter luciferase 
reporter and renilla luciferase internal control were treated with or without 50 μ g/ml of SiO2 NPs for 12 h. 
Luciferase activity was then detected and normalized to renilla activity. (C,D) A549 cells were treated with or 
without 50 μ g/ml of SiO2 NPs for 12 h. ChIP analysis was performed with antibodies against Ac-H3(9/18) (C) or 
H3K4me2 (D) and analyzed by qPCR. (E,F) Mouse lung was instilled with PBS or 100 μ g of SiO2 NPs for 1 day. 
ChIP analysis was performed with antibodies against Ac-H3(9/18) (E) or H3K4me2 (F) and analyzed by qPCR. 
The occupancies of Ac-H3(9/18) or H3K4me2 at FST promoter region were normalized to ACTB. The values are 
the mean ± SD of three independent experiments. *P < 0.05, **P < 0.01.
www.nature.com/scientificreports/
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expression, Nrf2 levels was decreased by siRNA (Fig. 4A,C). Knockdown of Nrf2 resulted in significant reduction 
of FST mRNA and protein expression under normal condition and SiO2 NP treatment (Fig. 4B,C), indicating that 
FST transcription is under the control of Nrf2.
By analyzing the FST gene proximal promoter, we identified a putative antioxidant response element (ARE), 
which is a consensus Nrf2-binding sequence (Fig. 4D). To determine the direct regulation of Nrf2 on FST expres-
sion, the luciferase reporters containing FST promoters with either wild-type or ARE-deleted sequences were 
used. Data revealed that luciferase activity of the wild-type FST promoter reporter was significantly reduced (to 
40% of control levels) following knockdown of Nrf2, indicating that FST promoter activity is Nrf2-dependent. 
However, deletion of ARE region completely abolished Nrf2 effect (Fig. 4E).
Finally, we sought to determine whether Nrf2 can directly bind to the FST promoter using ChIP assays. Data 
unveiled enrichment of FST promoter region (2.9 fold) but not ACTB gene following immunoprecipitation with 
the Nrf2 antibody. SiO2 NP treatment significantly increased Nrf2 binding (5.3 fold) to FST promoter (Fig. 4F). 
These data indicated that FST gene is a direct target of Nrf2.
FST protects against SiO2 NP-induced cell apoptosis. SiO2 NP treatment induces cellular toxicity 
both in vitro and in vivo1,18,19. Since FST expression was up-regulated in response to SiO2 NP, we suspected 
that FST has a protective role. To test this hypothesis, the expression of FST was down-regulated using siRNA 
(Fig. 5A,B) and cell viability was detected. Cell viability significantly decreased in FST silenced cells compared 
to control cells after SiO2 NP treatment (Fig. 5C). Decreased cell viability might be due to cell apoptosis. 
We therefore determined cellular apoptosis by annexin V-FITC staining method. The fractions of annexin 
V-positive cells were low in control groups (8.7 ± 1.4%, and 6.9 ± 0.9% respectively). SiO2 NP treatment 
markedly increased cell apoptosis in control siRNA-transfected cells (18.6 ± 1.4%), and elimination of FST 
enhanced the apoptotic tendency to 25.3 ± 1.0% (P < 0.01 compared to control) (Fig. 5D,E), indicating FST 
has a protective role in apoptosis.
FST protects against SiO2 NP toxicity in vivo. Next, we asked whether FST protects against SiO2 NP 
toxicity in lung tissue. To that end, the FST expression was down-regulated using virus-mediated shRNA and 
Figure 4. Nrf2 mediates FST induction during SiO2 NP treatment. (A–C) A549 cells transfected with 
siRNA targeting Nrf2 (siNrf2) or control siRNA were incubated with or without 50 μ g/ml of SiO2 NPs for 
another 12 h. The mRNA level of Nrf2 (A) and FST (B) was detected by qPCR and the protein level was 
detected by immunoblotting (C,D) Schematic of a luciferase reporter of the human FST promoter containing 
an evolutionarily conserved ARE among vertebrate species. (E) A549 cells transfected with siRNA targeting 
Nrf2 or control siRNA together with wild-type or ARE-deleted FST promoter luciferase reporter construct. 
Luciferase activity was measured 24 h following plasmid transfection. (F) A549 cells were treated with or 
without 50 μ g/ml of SiO2 NPs for 12 h. ChIP analysis was performed with antibodies against Nrf2 and analyzed 
by qPCR. The values are the mean ± SD of three independent experiments. *P < 0.05, **P < 0.01 (One way 
ANOVO).
www.nature.com/scientificreports/
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mice were treated with SiO2 NPs for 1 day. Cell apoptosis was then determined by TUNEL assays. Both qPCR 
and immunoblotting data showed that shRNA significantly reduced FST expression in mouse cells (Fig. 6A,B). 
Almost no TUNEL-positive cells were observed in the control group, while obvious TUNEL-positive staining was 
observed in SiO2 NP-treated lungs, indicating that SiO2 NP exposure induced cell apoptosis in lung tissue18,20. 
The number of TUNEL-positive cells increased in FST-KD group (Fig. 6C,D), indicating that FST protects against 
SiO2 NP toxicity in vivo.
FST inhibits SiO2 NP-induced ROS production and the expression of NOX1 and NOX5 
genes. The toxic effect of SiO2 NPs is mainly mediated by particle-induced oxidative stress1. We therefore 
determined whether FST exerts its protective function through inhibiting ROS production during SiO2 NP 
exposure. SiO2 NP treatment increased total ROS level in A549 cells. Knockdown of FST further increased ROS 
level while overexpression of FST decreased ROS level (Fig. 7A,B), indicating an inhibitory role of FST in SiO2 
NP-induced ROS production.
ROS is produced in mitochondria and by cytosolic NADPH oxidases (NOXs)21,22. Therefore, FST might 
inhibit ROS level by regulating either mitochondria or NOX functions. We firstly detected mitochondrial ROS 
level using MitoSOX assay and data showed that knockdown of FST did not affect mitochondrial ROS production 
(Fig. 7C). Next, we detected the expression of NOX1, NOX2, NOX3, NOX4, and NOX5, which are involved in 
cytosolic ROS production21. Our data showed that the mRNA levels of NOX2, NOX3 and NOX4 were very low 
in A549 cells. The mRNA levels of NOX1 and NOX5 significantly increased during SiO2 NP treatment, indicating 
that NOX1 and NOX5 are involved in SiO2 NP-induced cytosolic ROS synthesis. Knockdown of FST increased 
while overexpression of FST decreased the expression of NOX1 and NOX5 under both control and SiO2 NP 
treatment (Fig. 7D–G). These data suggested that FST inhibits NOX1 and NOX5 expression to regulate cytosolic 
ROS production.
Figure 5. FST protects against SiO2 NP-induced cell apoptosis. (A,B) A549 cells were transfected with siRNA 
targeting FST (siFST) or control siRNA (siCon). The FST mRNA level was detected by qPCR (A) and the FST 
protein level was detected by immunoblotting (B–E) A549 cells transfected with siRNA targeting FST (siFST) 
or control siRNA (siCon) were treated with or without 50 μ g/ml of SiO2 NPs for 12 h. (C) Cell viability was 
determined using cell counting kit-8 (CCK-8). (D) Cell apoptosis was monitored by annexin V-FITC staining 
and flow cytometry analysis. (E) Annexin-V positive cells were quantified. The values are the mean ± SD of 
three independent experiments. **P < 0.01.
www.nature.com/scientificreports/
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Discussion
The toxicity of SiO2 NPs has gained much attention with the fast growth of nanotechnology. Both in vitro and 
in vivo evidence has shown that SiO2 NPs induce toxic effect in respiratory system1,18,19. However, our under-
standing towards cellular responses to overcome the SiO2 NPs toxicity is still limited. In this report, we provided 
experimental evidence to support that FST is involved in cellular protective response to SiO2 NPs. The major 
findings of our study include: 1) SiO2 NPs induced endogenous expression of FST both in mouse lungs and 
in cultured lung epithelial cells; 2) SiO2 NPs activated FST transcription through Nrf2; 3) FST inhibited SiO2 
NP-induced apoptosis; 4) FST inhibited ROS production triggered by SiO2 NPs. These findings demonstrated a 
protective role of FST (Fig. 8) and might provide a better understanding of the interaction between SiO2 NPs and 
biological systems.
FST is a stress responsive gene and its expression can be induced by SiO2 NP treatment as well as glucose 
deprivation. However, the mechanism is totally different. We have shown that the induction of FST by glucose 
deprivation was due to an increase in the half-life of its mRNA. Under normal condition, AUF1 bound to AU-rich 
element in the 3’UTR of FST mRNA and promoted FST mRNA decay. During glucose deprivation, a majority of 
AUF1 shuttled from cytoplasm to nucleus, resulting in dissociation of AUF1 from FST mRNA and thus stabili-
zation of FST mRNA14. However, our present data showed that the half-life of FST mRNA did not change during 
SiO2 NP-treatment. On the contrary, the Ac-H3(K9/18) level and H3K4me2 level at FST promoter region signif-
icantly increased, indicating an activation of FST transcription. Therefore, SiO2 NP regulates FST expression at 
transcriptional level while glucose deprivation regulates FST expression at post-transcriptional level. This might 
be due to the different signaling activated. Glucose deprivation activates AMPK pathway and AMPK activation 
mediates FST induction during glucose deprivation as AMPK inhibition blocked the increase of FST mRNA14. 
On the contrary, SiO2 NPs mainly induce ROS generation and oxidative stress. SiO2 NP-induced ROS production 
Figure 6. FST protects against SiO2 NP toxicity in vivo. (A,B) Mouse embryo fibroblast cells were infected 
with viruses expressing shCon or shFST. The FST mRNA level was detected by qPCR (A) and the FST protein 
level was detected by immunoblotting (B–D) Mouse lung infected with shCon or shFST was instilled with PBS 
or 100 μ g of SiO2 NPs for 1 day. (C) Cell apoptosis was detected by TUNEL assay. (D) TUNEL positive cells were 
quantified. The values are the mean ± SD. **P < 0.01.
www.nature.com/scientificreports/
8Scientific RepoRts | 6:21133 | DOI: 10.1038/srep21133
activates transcription factor Nrf2, which induces FST transcription. This was supported by the decreased FST 
expression in Nrf2-deficient cells and the direct binding of Nrf2 to FST promoter region (Fig. 4).
How does FST exert its protective function during SiO2 NP treatment? NP-induced ROS generation and 
oxidative stress is the best-developed paradigm to explain the cellular responses to nanoparticles. Our data 
demonstrated that FST inhibited NOX1 and NOX5 expression and ROS production, indicating that the pro-
tective effect of FST is due to the ROS-inhibition. Although the detailed mechanism by which FST inhibits ROS 
production is still unclear, there are clues pointing to the TGF-β -like molecule-neutralizing effect of FST. It has 
been reported that TGF-beta family members increased cellular ROS level in a variety of cell lines while FST 
antagonized their effects. For example, myostatin induced oxidative stress by producing ROS in skeletal muscle 
Figure 7. FST inhibits SiO2 NP-induced ROS production. (A) A549 cells transfected with siRNA targeting 
FST (siFST) or FST gene (FST/OE) were treated with or without 50 μ g/ml of SiO2 NPs for 12 h. Intracellular 
ROS generation was detected by DCFH-DA fluorescent probe and flow cytometry. (B) Relative ROS level 
was calculated. The values are the mean ± SD of three independent experiments. **P < 0.01. (C) A549 cells 
transfected with siRNA targeting FST (siFST) were treated with or without SiO2 NPs for 12 h. Mitochondrial 
ROS was detected using MitoSOX. (D,E) A549 cells transfected with control siRNA or siRNA targeting FST 
(siFST) were treated with or without 50 μ g/ml of SiO2 NPs for 12 h. The mRNA level of NOX1 (D) and NOX5 
(E) was measured by real time qPCR. (F,G) A549 cells overexpressing FST gene were treated with or without 
50 μ g/ml of SiO2 NPs for 12 h. The mRNA level of NOX1 (F) and NOX5 (G) was measured by real time qPCR. 
The data are presented as the mean ± SD of three independent experiments. **P < 0.01.
Figure 8. Schematic model for the role of FST in protecting against SiO2 NP toxicity. SiO2 NPs induce 
cellular ROS production through multiple pathways including the activation of NOX1 and NOX5. The 
increased cellular ROS activates the transcription factor Nrf2 which induces the transcription of FST. FST 
further inhibits the expression of NOX1 and NOX5. This negative feedback loop maintains cellular ROS 
homeostasis during SiO2 NP exposure (left panel). Elimination of FST breaks the feedback loop which increases 
cellular ROS level and induces cell apoptosis (right panel).
www.nature.com/scientificreports/
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cells23. Activin induced endothelial cell oxidative stress and endothelial cell dysfunction, and these effects are 
mitigated by follistatin15. BMP4 treatment increased ROS levels in basal progenitor cells, while follistatin inhib-
ited BMP4-induced ROS production16. All these data support that FST is a negative regulator of cellular ROS 
production.
Nanoparticles were reported to induce general toxic effects on cells such as oxidative stress, inflammation 
and cell death. However, different NPs have different physic-chemical properties, they might induce NP-specific 
cytotoxicity. For example, a panel of industrially most relevant metal oxide nanoparticles was screened for toxic 
effects in A549 cells. Data showed that SiO2 NPs induced acute cytotoxicity, which is consistent with our results. 
SiO2 NPs also induced the expression of COX-2, TNF-α , IL-1β , IL-6 and IL-8. However, iron oxide- or titania- 
NPs were not cytotoxic and only specifically induced TNF-α expression24. Due to the different cytotoxicity, the 
following cellular protective responses might also be different. Shi J et al. reported that microsomal glutathione 
transferase 1 (MGST1) protected against SiO2 nanoparticle-induced oxidative stress and cytotoxicity, while it 
failed to prevent ZnO nanoparticle-triggered cell death25. Our data showed that FST can also be induced by TiO2 
NPs, Ag NPs, and ZnO NPs, but the expression level of FST did not change significantly under gold nanorods 
(GNRs) or graphene oxide (GO) treatment (Fig. S4). These data indicated the existence of different mechanism 
of cytotoxicity of different nanoparticles.
In summary, we have identified FST as a SiO2 NP-responsive protein that protects against SiO2 NP lung tox-
icity. These findings point to a protective strategy for respiratory system to overcome SiO2 NP-induced adverse 
effects.
Materials and Methods
Silica nanoparticles. SiO2 nanoparticle was from Sigma-Aldrich (#637238, Sigma-Aldrich, St. Louis, 
MO, United States). Nanoparticles were dispersed in double distilled water at the concentration of 10 mg/mL. 
Nanoparticles were sonicated at 200 W for 30 seconds prior to cell or mouse treatment.
Transmission electron microscope (TEM) was taken by a JEOL JEM-1200EX transmission electron micro-
scope for nanoparticles. SiO2 NPs were dispersed in Roswell Park Memorial Institute (RPMI)-1640 medium 
(Invitrogen, Carlsbad, CA, United States) for 0 h and 24 h and then subjected to dynamic light scattering (DLS) 
and zeta-potential measurements using the instrument Zetasizer Nano ZS-90 (Malvern Instruments, Orsay, 
France).
Cells culture and nanoparticle treatment. Lung epithelial cells (A549) were obtained from ATCC and 
cultured in RPMI-1640 medium supplemented with 10% fetal bovine serum (Thermo Fisher Scientific, Waltham, 
MA, United States). Cells were maintained at 37 °C in an atmosphere containing 5% CO2 and 100% humidity.
For SiO2 NP treatment, cells were seeded in 6-well plates. After 24 hours, cells were treated with silica nan-
oparticles suspended in RPMI-1640 supplemented with 1% fetal bovine serum at different concentration for 
indicated time and then subjected to further experiments.
Plasmids. Plasmid expressing FST288 was kindly provided by Dr. Henry T. Keutmann (Massachusetts 
General Hospital).
For the construction of FST promoter plasmid, FST promoter region was amplified by PCR and cloned to 
vector pGL3-basic between XhoI and HindIII sites. To construct Nrf2-binding site deletion mutant, the 5’ and 3’ 
parts of FST promoter region was amplified and ligated using BamHI site.
For the construction of shRNA plasmid targeting FST, lentviral vector pLVX-shRNA1 was used. shRNA oligo-
nucleotides were designed using online protocol www.clontech.com. Oligo sequences were listed in supplemen-
tal Table 1. Synthesized DNA oligos were annealed and ligated into the BamHI/EcoRI-digested pLVX-shRNA1 
vector.
RNA purification and reverse transcription reaction. Total RNA was isolated with Trizol reagent 
(Invitrogen) following the manufacturer’s protocol. 0.5 μ g of total RNA was reverse transcribed using random 
hexamers and the High Capacity cDNA Reverse Transcription Kit (Life Technologies, Grand Island, NY, United 
States).
Real-time quantitative PCR analysis. Real-time quantitative PCR analysis was performed in 10-μ l reac-
tions using SYBR GREEN PCR Master Mix (Applied Biosystems). The related mRNA level was normalized to the 
β-actin mRNA level. Data were analyzed using the 2−ΔΔCt method26. Sequences of all the primers used for PCR 
amplification are listed in supplemental Table 1.
Immunoblotting analysis. Proteins were quantified by BCA protein assay kit (Bio-Rad) and applied to 
immunoblotting analysis as described previously [2]. 50 μ g of total proteins were subjected to sodium dodecylsul-
fate polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to nitrocellulose membrane (Whatman, 
Clifton, NJ, United States). Membrane was blocked with 3% bovine serum albumin (BSA) TBS-T buffer (20 mM 
Tris-HCl, pH 8.0, 150 mM NaCl, 0.05% Tween- 20), probed with antibodies targeting to FST (Santa Cruz 
Biotechnology, Santa Cruz, CA, United States), or ACTB (Cell Signaling Technology, Beverly, MA, United States). 
Membrane was incubated with horseradish-conjugated secondary antibodies, detected with the SuperSignal West 
Pico chemiluminescence substrate (Thermo Fisher Scientific), and finally exposed to an X-ray film. Alternatively, 
membrane was incubated with fluorescent secondary antibodies, and visualized by an Odyssey imaging system 
(Li-COR Biosciences, Lincoln, NE, United States).
Immunohistochemistry. Embedded mouse lung tissues were deparaffinized with xylene, rehydrated in 
ethanol, and boiled in 10 mM citrate buffer (pH 6.0) for 30 min for antigen retrieval. Endogenous peroxidase 
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was blocked by treatment with 3% H2O2. After blocking in goat serum for 30 min at room temperature, tissues 
were incubated with anti-FST (Santa Cruz Biotechnology) at 4 °C overnight. The slides were then visualized with 
Envision System (DAKO Corporation, Carpinteria, CA, United States) and counterstained with hematoxylin. 
Images were captured with a wide field microscope (Nikon Eclipse Ti, Nikon Instruments Inc., Shanghai, China).
RNA interference. For knockdown experiments, A549 cells were transiently transfected with 100 pmol of 
the chemically synthesized siRNAs targeting FST or the negative control siRNA using LipofectamineRNAiMAX 
(Invitrogen) following the manufacturer’s recommendations. Cells were harvested 48 hours post-transfection. 
siRNAs were synthesized by GenePhama company (Shanghai, China). siRNA sequences used are designed as 
follows: FST siRNA, forward, GAUCUAUUGGAUUAGCCUATT, reverse, UAGGCUAAUCCAAUAGAUCTT; 
Nrf2 siRNA, forward, GAAUGGUCCUAAAACACCATT, reverse, UGGUGUUUUAGGACCAUUCTT; negative 
control siRNA, forward, UUCUCCGAACGUGUCACGUTT, reverse, ACGUGACACGUUCGGAGAATT.
Luciferase assay. A549 cells were transfected with FST promoter and pRL-TK was co-transfected as the 
internal control. 24 hours after transfection, cells were treated with SiO2 NPs for another 12 hours. Cells were then 
lysed and luciferase activity was measured by the Dual-Luciferase assay system (Promega, Madison, WI, United 
States). The firefly luciferase activity was normalized to renilla luciferase.
ROS detection. Total ROS was detected by using a fluorescent probe 2’,7’-dichlorofluorescin-diacetate 
(DCFH-DA) (Beyotime, Nanjing, China). Briefly, cultured A549 cells were treated with or without SiO2 NPs for 
12 h and then incubated with 10 μ M of DCFH-DA at 37 °C for 30 minutes. After rinsing with PBS to eliminate 
excess DCFH-DA, cells were harvested in 0.5 ml PBS and the fluorescence intensity was monitored with flow 
cytometry (FCM).
MitoSOX (Invitrogen) was used to detect mitochondrial ROS. Cultured A549 cells were collected and incu-
bated with 10 μ M of MitoSOX at 37 °C for 30 minutes and the fluorescence intensity was monitored with flow 
cytometry.
Apoptosis assay. Cells seeded in 6-well plates were transfected with siRNAs or plasmids for 48 hours. After 
SiO2 NP treatment for 12 hours, both floating and attached cells were harvested and applied to annexin V detec-
tion. Briefly, resuspended cells were stained with 5 μ l of annexin V-FITC (Biovision, Mountain View, CA, United 
States) for 5 minutes in the dark and then analyzed by flow cytometry (Beckman Coulter, Brea, CA, United States).
CCK8-based viability assay. The effect of SiO2 NP on cell viability was assessed by Cell Counting Kit-8 
(CCK8) assay (Dojindo Laboratory, Japan). A549 cells plated in 96-well plate were transfected with siRNAs for 
48 hours. Cells were then treated with SiO2 NPs for another 12 hours. 10 μ l of CCK8 reagent was added to each 
well and the cells were incubated for 2 hours at 37 °C. The optical density (OD) at 450 nm was measured by using 
VarioskanFlash (Thermo Scientific).
shRNA plasmid construction. To produce lentivirus expressing FST-shRNA, the plasmid pLVX-shFST, 
the envelope plasmid pMD2G and the packaging plasmid psPAX2 were co-transfected into 293T cells. Lentiviral 
supernatants were harvested through a 0.45 μ m filter 48 hours after transfection. Equal amount of Lentiviral 
supernatants were used for knockdown of FST in cultured cells and in mouse lung tissue.
Mouse treatment. Male ICR mice of six weeks of age were used for the study. Mice were instilled intratra-
cheally with PBS or 100 μ g of SiO2 NPs for indicated time and then sacrificed18. Mice lung tissue was fixed in 10% 
formalin or stored in liquid nitrogen for mRNA and protein extraction. All studies were performed following 
the ethical guidelines of the Ethics Committee of Laboratory Animal Care and Welfare, Zhejiang University, 
School of Medicine. All studies were approved by the Ethics Committee of Laboratory Animal Care and Welfare, 
Zhejiang University, School of Medicine.
Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay. TUNEL assays 
were performed using the TUNEL assay kit (Promega, Madison, WI, United States) to assess cell death following 
the manufacture’s instruction. Localized green fluorescence of apoptotic tissue was detected with the Nikon A1R 
confocal microscope (Nikon Instruments Inc., Shanghai, China).
Chromatin immunoprecipitation (ChIP). ChIP assays were performed using the ChIP assay kit 
(Thermo Fisher Scientific) following the manufacturer’s protocol. Briefly, A549 cells or mouse lung tissues were 
cross-linked with 1% formaldehyde for 10 min at 37 °C. Cross-linking was stopped with 0.125 M glycine. For 
tissue ChIP, mouse lung tissue was grounded and the cells were resuspended in lysis buffer. After sonication to 
yield DNA fragments of 300–1000 base pairs, the lysates were cleared by centrifugation, diluted 6-fold with ChIP 
dilution buffer, and precleared with salmon sperm DNA/protein A-agarose at 4 °C for 1 h. For each immunopre-
cipitation assay, the lysates were incubated with 2 μ g of anti-K4-dimethylated histone H3 (H3K4me2) (Thermo 
Fisher Scientific), anti-acetylated histone H3 (Lys9/18) (Ac-H3, K9/18) (Thermo Fisher Scientific), Nrf2 (Abcam, 
Cambridge, MA, United States) or control IgGs (Santa Cruz Biotechnology) overnight at 4 °C with rotation. 
The immunecomplexes were then collected with protein A-agarose slurry, eluted, and de-crosslinked at 65 °C. 
After RNase digestion and proteinase digestion, immunoprecipitated DNA was extracted. The purified DNA was 
amplified by real time PCR with SYBR GREEN PCR Master Mix (Applied Biosystems).
Sequences of the primers used for FST promoter amplification are listed in supplemental Table 1.
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Statistical analysis. The experiments were repeated at least three times and data were presented as 
mean ± SD. Statistical significance between two groups was determined with the Student’s t-test. Statistical signif-
icance among more than 3 groups was determined with one-way analysis of variance (ANOVA). All comparisons 
were two-tailed and P < 0.05 was considered significant.
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